tiprankstipranks
Viveon Health Acquisition (VHAQ)
NYSE MKT:VHAQ
US Market
Holding VHAQ?
Track your performance easily

Viveon Health Acquisition (VHAQ) Income Statement

4 Followers

Viveon Health Acquisition Income Statement

Last quarter (Q ), Viveon Health Acquisition's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Viveon Health Acquisition's net income was $2.95M. See Viveon Health Acquisition’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20
Total Revenue
---$ 0.00
Cost of Revenue
$ 1.00M$ 500.00K$ 500.00K-
Gross Profit
$ -1.00M$ -500.00K$ -500.00K-
Operating Expense
$ 2.37M$ 2.37M$ 4.11M$ 450.47K
Operating Income
$ -2.37M$ -2.37M$ -4.11M$ -450.47K
Net Non Operating Interest Income Expense
$ -6.85M$ -3.65M$ 20.48K$ 213.00
Other Income Expense
$ 253.71K$ -5.59M$ -6.60M$ -1.79M
Pretax Income
$ -425.48K$ -425.48K$ 2.49M$ -2.24M
Tax Provision
$ 61.31K$ 61.31K$ -824.92K-
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -486.79K$ -486.79K$ 2.49M$ -2.24M
Basic EPS
$ -0.04$ -0.04$ 0.10$ -0.91
Diluted EPS
$ -0.04$ -0.04$ 0.10$ -0.91
Basic Average Shares
$ 52.31M$ 12.22M$ 24.15M$ 2.47M
Diluted Average Shares
$ 52.31M$ 12.22M$ 24.15M$ 2.47M
Dividend Per Share
-$ 2.00--
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 3.37M$ 2.87M$ 4.61M$ 450.47K
Net Income From Continuing And Discontinued Operation
$ -486.79K$ -486.79K$ 2.49M$ -2.24M
Normalized Income
$ -5.32M$ -2.46M-$ -475.23K
Interest Expense
$ 359.29K---
EBIT
$ 3.09M$ 3.22M$ 2.49M$ -450.47K
EBITDA
$ 6.39M$ 7.26M$ 2.49M$ -450.47K
Currency in USD

Viveon Health Acquisition Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis